These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3663953)

  • 1. Resistance to endocrine therapy. A panel discussion.
    McGuire WL; Lippman ME; Osborne CK; Thompson EB
    Breast Cancer Res Treat; 1987; 9(3):165-73. PubMed ID: 3663953
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone therapy of patients with breast cancer].
    Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1984; 30(11):3-9. PubMed ID: 6393574
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological receptor determination in endocrine therapy of breast cancer.
    Segaloff A
    Annu Rev Pharmacol Toxicol; 1980; 20():429-39. PubMed ID: 6247961
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relation between estrogen and progesterone receptors and response to hormone therapy].
    Leclercq G; Paridaens R; Heuson JC
    Pathol Biol (Paris); 1983 Dec; 31(10):793-800. PubMed ID: 6366700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
    Jia X; Hong Q; Lei L; Li D; Li J; Mo M; Wang Y; Shao Z; Shen Z; Cheng J; Liu G
    Oncotarget; 2015 Apr; 6(11):8648-62. PubMed ID: 25929338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundamental research leading to improved endocrine therapy for breast cancer.
    Miller WR
    J Steroid Biochem; 1987; 27(1-3):477-85. PubMed ID: 3320538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors].
    Jovanović-Mićić D; Beleslin DB; Nikolić SS
    Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro testing of cytotoxic compounds in hormone-dependent and -independent breast cancer cell lines.
    Leclercq G; Devleeschouwer N; Heuson JC
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():163-72. PubMed ID: 6733716
    [No Abstract]   [Full Text] [Related]  

  • 10. [Breast cancer--topics from basic research].
    Matsumoto K; Kuroda H; Takeyama M
    Gan To Kagaku Ryoho; 1984 May; 11(5):974-80. PubMed ID: 6721515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?
    Purushotham A; Pinder S; Cariati M; Harries M; Goldhirsch A
    J Clin Oncol; 2010 Aug; 28(22):3552-4. PubMed ID: 20606095
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent progress of endocrine therapy in breast cancer].
    Nomura Y
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):783-9. PubMed ID: 1605654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogen and progesterone receptors in carcinoma of the breast].
    Musiani P; Piantelli M; Dina MA
    Pathologica; 1979; 71(1011):1-7. PubMed ID: 450473
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects and mechanism of action of antiestrogens in breast cancer].
    Borgna JL; Rochefort H
    Sem Hop; 1984 Mar; 60(10):703-9. PubMed ID: 6322320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term results of adjuvant endocrine therapy for hormone receptor-positive breast cancer].
    Semilgazov VF; Manikhas AG; Semiglazov VV; Bozhok AA; Dashian GA; Ivanov VG; Paltuev RM; Vasil'ev AG; Shchedrin DE; Ermachenkova AM; Nikitina IV; Pen'kov KD; Bessonov AA; Tabagua TT; Kolar'kova VV
    Vopr Onkol; 2011; 57(5):567-77. PubMed ID: 22238925
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endocrine therapies in breast cancer].
    Schnürch HG
    Gynakologe; 1993 Apr; 26(2):107-17. PubMed ID: 7685309
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocrine treatment for breast cancers: biological rationale and current progress.
    Miller WR
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):467-80. PubMed ID: 2278830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone receptors and Japanese breast cancer.
    Matsumoto K; Kitamura Y; Sugano H
    Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor determination by monoclonal antibody in fine needle aspiration breast cancer cytologies: a marker of hormone response.
    Burton GV; Flowers JL; Cox EB; Leight GS; Dent GA; Geisinger KR; McCarty KS; McCarty KS
    Breast Cancer Res Treat; 1987 Dec; 10(3):287-91. PubMed ID: 3447647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical relevance of the determination of hormone receptors in metastatic breast cancer].
    Saul G; Rose H; Riessbeck KH; Sinn B
    Radiobiol Radiother (Berl); 1987; 28(1):33-7. PubMed ID: 3588856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.